💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Amicus Therapeutics, Inc. (FOLD)
« Back to company indexFOLD Chatter Timeline
Stock Ticker for FOLD
Most Active Tweeters for FOLD
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @stock_titan | 6 |
| @TradeWithAlerts | 5 |
| @Traderofstocks1 | 5 |
| @FlashAlert_me | 5 |
Recent Tweets for FOLD
 |
@mikehuddie1q RT @danushman: $FOLD Opened a position in this name earlier today. Cross your fingers, toes, and ears for me! Bottom fishing again :) http… May 8th 2021, 1:05pm |
|
@mikehuddie1q RT @danushman: $FOLD step by step https://t.co/bfYLYgkSyG May 8th 2021, 1:05pm |
|
@mikehuddie1q RT @danushman: $FOLD https://t.co/nCS0DKEBXv May 8th 2021, 9:05am |
 |
@newsfilterio Amicus Therapeutics to Present at Upcoming Investor Conferences in May 2021 $FOLD https://t.co/P7jlFTPQ8M May 8th 2021, 3:05am |
 |
@Tickeron $FOLD's price moved below its 50-day Moving Average on May 4, 2021. View odds for this and other indicators:… https://t.co/W4cqn7MaPX May 7th 2021, 9:05pm |
 |
@TradeWithAlerts Nice Print for $FOLD - Amount: $3,560,076.00 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt! May 7th 2021, 8:05pm |
 |
@FlashAlert_me $FOLD [15s. delayed]: Issued Press Release on May 07, 07:00:00: Amicus Therapeutics to Present at Upcoming Investor… https://t.co/eBWEa9w0OK May 7th 2021, 11:05am |
 |
@kevinjaybe $FOLD Amicus Therapeutics To Present At Upcoming Investor Conferences In May 2021 https://t.co/oUVVEQEIfC May 7th 2021, 11:05am |
 |
@stock_titan $FOLD Amicus Therapeutics to Present at Upcoming Investor Conferences in May 2021 https://t.co/3j84XA4msL May 7th 2021, 11:05am |
|
@Tickeron $FOLD's price moved below its 50-day Moving Average on May 4, 2021. View odds for this and other indicators:… https://t.co/FK6Tzv8BSI May 7th 2021, 8:05am |
 |
@Sarah_Katilyn $FOLD been watching for a bit. May take a starter https://t.co/dLaxbWbBRV May 6th 2021, 10:05pm |
 |
@MarcJacksonLA $FOLD Amicus Therapeutics Appoints Sébastien Martel as Senior Vice President of Strategy and Business Development https://t.co/XDoV31u3Uc May 6th 2021, 1:05pm |
 |
@Traderofstocks1 $FOLD https://t.co/ccJfWF9GXW May 6th 2021, 1:05pm |
 |
@BioWino welp.. more stock options.. more cash burn $fold https://t.co/guklIvMZPP May 6th 2021, 12:05pm |
 |
@sbwcws Amicus appoints Sebastien Martel as SVP, strategy and business development $FOLD $SNY May 6th 2021, 12:05pm |
|
@FlashAlert_me $FOLD [15s. delayed]: Issued Press Release on May 06, 07:00:00: Amicus Therapeutics Appoints Sébastien Martel as Se… https://t.co/MTt8A5sOTM May 6th 2021, 11:05am |
|
@kevinjaybe $FOLD Amicus Therapeutics Appoints Sébastien Martel As Senior Vice President Of Strategy And Business Development https://t.co/Uxpd532XuC May 6th 2021, 11:05am |
|
@stock_titan $FOLD Amicus Therapeutics Appoints Sébastien Martel as Senior Vice President of Strategy and Business Development https://t.co/CfYPJohl14 May 6th 2021, 11:05am |
 |
@Artificialbra1n RT @aistockfinder: $FOLD https://t.co/QOyJuIQJrk Amicus Therapeutics Inc. Our Artificial Intelligence has forecasted this company s stock p… May 6th 2021, 5:05am |
 |
@aistockfinder $FOLD https://t.co/QOyJuIQJrk Amicus Therapeutics Inc. Our Artificial Intelligence has forecasted this company s st… https://t.co/rQkCuuuOCb May 6th 2021, 4:05am |
 |
@StockTexts $FOLD Amicus Therapeutics, Inc. SEC Filing: Form 4 https://t.co/kik1nNA9AW May 5th 2021, 10:05pm |
 |
@WALLSTREETODDS_ $FOLD Out of the 674 other times FOLD was down 4.2% during a trading day, 56% of the time it traded higher by the… https://t.co/qrjkkTDGrn May 5th 2021, 1:05pm |
|
@stock_titan $FOLD Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 24th Annu… https://t.co/GEDBenunbE May 5th 2021, 11:05am |
|
@Traderofstocks1 $FOLD Top pick ready to break out: https://t.co/ccJfWF9GXW May 5th 2021, 4:05am |
|
@WALLSTREETODDS_ $FOLD Out of the 360 other times FOLD was down 5.6% during a trading day, 57% of the time it traded higher by the… https://t.co/wMpuwlGgCW May 5th 2021, 1:05am |
|
@TradeWithAlerts Nice Print for $FOLD - Amount: $5,861,887.93 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt! May 4th 2021, 8:05pm |
 |
@moneymessage_ $FOLD - Amicus Therapeutics announces pre-BLA meeting with FDA for AT-GAA in Pompe disease https://t.co/8dDdaRW9ma May 3rd 2021, 4:05pm |
 |
@GapUp4 $FOLD Amicus Therapeutics Concludes Pre-BLA Meeting With FDA For AT-GAA In Pompe Disease May 3rd 2021, 3:05pm |
|
@MarcJacksonLA $FOLD Amicus Therapeutics Announces Successful Pre-BLA Meeting With US FDA For AT-GAA for Pompe Disease https://t.co/NTUMyq47fE May 3rd 2021, 2:05pm |
|
@MarcJacksonLA $FOLD Amicus Therapeutics Concludes Pre-BLA Meeting With FDA For AT-GAA In Pompe Disease $FOLD https://t.co/yPNY5WGyeB # via @benzinga May 3rd 2021, 2:05pm |
 |
@Gambiste1 RT @HFTAlert: These two issues, $COIN and $FOLD many of our users are playing long from last week. Both display supportive Accumulators...… May 3rd 2021, 2:05pm |
 |
@HFTAlert These two issues, $COIN and $FOLD many of our users are playing long from last week. Both display supportive Accum… https://t.co/g09Rjr22Jp May 3rd 2021, 2:05pm |
 |
@DaytradingArts $FOLD launch... May 3rd 2021, 2:05pm |
|
@Gambiste1 RT @print_trading: Amicus Therapeutics Finishes Pre-BLA Meeting With FDA for AT-GAA $FOLD May 3rd 2021, 1:05pm |
 |
@saltadogato $FOLD - hard to say today's news is definitively positive; but it is not negative and the stock has already been cu… https://t.co/H4RIUeFmlG May 3rd 2021, 1:05pm |
 |
@Briefingcom $FOLD: Amicus Therapeutics reports successful pre-BLA meeting with FDA for AT-GAA https://t.co/FIeB1GxgSn May 3rd 2021, 1:05pm |
 |
@print_trading Amicus Therapeutics Finishes Pre-BLA Meeting With FDA for AT-GAA $FOLD May 3rd 2021, 1:05pm |
|
@Gambiste1 RT @BankTheTrade: $FOLD(9.84) up .80 ...said it has completed a successful type B pre-biologics license application meeting with the US Foo… May 3rd 2021, 1:05pm |
 |
@gixxer144 RT @FearLessTraDeRx: $FOLD Amicus Therapeutics Reports Successful Pre-BLA Meeting With FDA for AT-GAA to Treat Pompe Disease; Shares Up Pr… May 3rd 2021, 1:05pm |
 |
@SwingTradeBot Recent $FOLD technical alerts: Narrow Range Bar plus 2 more alerts... https://t.co/mBVJ3SPeRU May 3rd 2021, 1:05pm |
 |
@2ndwavve Needs vol. on watch Pompe has a high mortality rate. $FOLD Amicus Therapeutics Announces Successful Pre-BLA Meeting… https://t.co/RinGARccMu May 3rd 2021, 1:05pm |
 |
@BankTheTrade $FOLD(9.84) up .80 ...said it has completed a successful type B pre-biologics license application meeting with the… https://t.co/X64wkeMm3g May 3rd 2021, 12:05pm |
 |
@NewsQuantified $FOLD today announced the completion of a successful Type B Pre-Biologics License Application meeting with the U.S.… https://t.co/BDx3cQAWFI May 3rd 2021, 12:05pm |
 |
@edtaussig RT @BioStocks: $FOLD Announces Successful Pre-BLA Meeting for AT-GAA for the Treatment of Pompe Disease. Completion of Rolling BLA On-Trac… May 3rd 2021, 12:05pm |
 |
@FearLessTraDeRx $FOLD Amicus Therapeutics Reports Successful Pre-BLA Meeting With FDA for AT-GAA to Treat Pompe Disease; Shares Up Pre-Bell May 3rd 2021, 11:05am |
 |
@StuckInStock Another gain for $FOLD vs competition. $AVRO can no longer pursue accelerated approval for AVR-RD-01 with the FAB-G… https://t.co/mZ8jvV16l8 May 3rd 2021, 11:05am |
|
@StuckInStock $FOLD Amicus Therapeutics Announces Successful Pre-BLA Meeting with FDA for AT-GAA (Pompe Disease): -Existing Dat… https://t.co/Ojg0oZfBTa May 3rd 2021, 11:05am |
|
@StockTexts $FOLD Amicus Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/lkMcLWR8fd May 3rd 2021, 11:05am |
 |
@glitchbotio RT @MarketCurrents: $FOLD - Amicus Therapeutics announces pre-BLA meeting with FDA for AT-GAA in Pompe disease https://t.co/nVYQkrhBaw May 3rd 2021, 11:05am |
 |
@MarketCurrents $FOLD - Amicus Therapeutics announces pre-BLA meeting with FDA for AT-GAA in Pompe disease https://t.co/nVYQkrhBaw May 3rd 2021, 11:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
